'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on: March 30,2024

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on:March 30,2024

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Updated on: January 04,2024

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Updated on:January 04,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on: September 27,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on:September 27,2024

Researchers identify promising drug to treat gastrointestinal cancers

by Joe Dangor,Mayo ClinicCredit: Unsplash/CC0 Public DomainGastrointestinal cancers are some of the most commonly diagnosed cancers, and they continue to be associated with poor survival outcome

Updated on: April 07,2024

Researchers identify promising drug to treat gastrointestinal cancers

by Joe Dangor,Mayo ClinicCredit: Unsplash/CC0 Public DomainGastrointestinal cancers are some of the most commonly diagnosed cancers, and they continue to be associated with poor survival outcome

Updated on:April 07,2024

Brain cancer breakthroughs using the immune system offer hope against glioblastoma

by Lisa Jarvis, Bloomberg OpinionCredit: Human Brain ProjectA flurry of new studies suggest scientists are finally figuring out how to harness the immune system to attack a ruthless form of brain canc

Updated on: March 30,2024

Brain cancer breakthroughs using the immune system offer hope against glioblastoma

by Lisa Jarvis, Bloomberg OpinionCredit: Human Brain ProjectA flurry of new studies suggest scientists are finally figuring out how to harness the immune system to attack a ruthless form of brain canc

Updated on:March 30,2024

Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainCAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even fo

Updated on: January 25,2024

Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainCAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even fo

Updated on:January 25,2024

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on: April 29,2024

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on:April 29,2024

New cancer immunotherapy approach turns human cells into tiny anti-tumor drug factories

by University of California - San DiegoUC San Diego School of Medicine researchers developed a method to use B cells to manufacture and secrete microRNA-containing vesicles and showed they can in

Updated on: March 12,2024

New cancer immunotherapy approach turns human cells into tiny anti-tumor drug factories

by University of California - San DiegoUC San Diego School of Medicine researchers developed a method to use B cells to manufacture and secrete microRNA-containing vesicles and showed they can in

Updated on:March 12,2024

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t

Updated on: January 26,2024

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t

Updated on:January 26,2024

Muscle wasting severity linked to type, size and location of tumor in mice

byPennsylvania State UniversitySkeletal muscle fibers. Credit: Berkshire Community College Bioscience Image Library / Public domainAbout 80% of people with cancer suffer from significant muscle

Updated on: January 11,2024

Muscle wasting severity linked to type, size and location of tumor in mice

byPennsylvania State UniversitySkeletal muscle fibers. Credit: Berkshire Community College Bioscience Image Library / Public domainAbout 80% of people with cancer suffer from significant muscle

Updated on:January 11,2024

How Leukemia Is Treated

How Leukemia Is TreatedByKaren RaymaakersUpdated on January 22, 2023Medically reviewed byDouglas A. Nelson, MDThe treatment forleukemiadepends on many factors inclu

Updated on: February 04,2024

How Leukemia Is Treated

How Leukemia Is TreatedByKaren RaymaakersUpdated on January 22, 2023Medically reviewed byDouglas A. Nelson, MDThe treatment forleukemiadepends on many factors inclu

Updated on:February 04,2024

Circular RNAs—the new frontier in cancer research

byFlinders UniversityCircular RNA biogenesis and how they are dysregulated in cancer. Credit:Nature Reviews Cancer(2024). DOI: 10.1038/s41568-024-00721-7Unraveling the complexities o

Updated on: August 27,2024

Circular RNAs—the new frontier in cancer research

byFlinders UniversityCircular RNA biogenesis and how they are dysregulated in cancer. Credit:Nature Reviews Cancer(2024). DOI: 10.1038/s41568-024-00721-7Unraveling the complexities o

Updated on:August 27,2024